A Phase I Study of SAHA and Temozolomide in Children With Relapsed or Refractory Primary Brain or Spinal Cord Tumors.

Trial Profile

A Phase I Study of SAHA and Temozolomide in Children With Relapsed or Refractory Primary Brain or Spinal Cord Tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 May 2013

At a glance

  • Drugs Temozolomide (Primary) ; Vorinostat (Primary)
  • Indications Brain cancer; CNS cancer; Glioma
  • Focus Adverse reactions; Biomarker; Pharmacokinetics
  • Most Recent Events

    • 31 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 23 May 2012 Planned end date changed from 1 Jan 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.
    • 14 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top